Nieuws
Ten Create Health projects
Voor de subsidieoproep ‘Kennisbasis e-health voor gezond en actief ouder worden’ die in het najaar van 2016 is uitgezet, hebben tien aanvragen definitieve honoreringen ontvangen. Deze subsidieoproep valt binnen het programma Create Health van ZonMw, dat als doel heeft om bij te dragen aan de maatschappelijke uitdaging rondom gezond en actief ouder worden.
BIO-Europe Spring Amsterdam 2018 turns orange
Last week, BIO-Europe Spring took place in Amsterdam. Over 2,500 life sciences professionals gathered in our country’s capital city to engage in three full days of partnering meetings, educational sessions and networking. The conference, organized by the EBD Group, is one of Europe’s largest and most successful partnering conferences for the biotech and pharmaceutical industry. Thanks to this edition’s national partner Health~Holland, the conference not only turned orange, but also convincingly presented the Netherlands as Europe’s most attractive and innovative biopharmaceutical environment.
Submit your private investments in R&D this spring!
Top Sector Life Sciences & Health (LSH) supports innovative research and development realised by public-private partnerships (PPPs). The Top Sector brings together stakeholders in a shared, consolidated innovation infrastructure. By means of PPP Allowance, the Top Sector provides a financial instrument to help consortia consisting of research organisations, knowledge institutes, companies, and health foundations to realise their innovative ideas.
New Health Deal on stimulating health through personal prevention via e-health
In 2020, ten percent of the Netherlands will use e-health for personal prevention.That is one of the concrete goals of the recently signed Health Deal 'Stimulating health through personal prevention via e-health.'The Ministry of Economic Affairs and Climate Policy, the Ministry Health, Welfare and Sport and twelve other parties signed the Health Deal during the Health Valley Event on 15 March.The participants promise to undertake efforts to make e-health tools for personal prevention accessible to all Dutch people.
CiMaas has been granted patent on DC maturation technology
CiMaas, a biotech company developing innovative cellular immunotherapy, announced the grant of a European Patent on its Dendritic Cells maturation technology, an essential part of its Dendritic Cell Vaccine Product.Winners National Healthcare Innovation Award 2018 announced
Tijdens de slotshow op het Health Valley Event 2018 op 15 maart 2018 in het CineMec Nijmegen, is de CRDL door de vakjury uitgeroepen tot winnaar van de Nationale Zorginnovatieprijs 2018. Het publiek koos Abena Nova als winnaar van de publieksprijs. De Nationale Zorginnovatieprijs is een jaarlijks terugkerend initiatief van Stichting Zorginnovatie Nederland, om scale-ups in de zorg- en welzijnssector te steunen. De CRDL ontvangt een bedrag van €10.000 en Abena Nova een bedrag van €5.000,- dat zij kunnen investeren in verdere opschaling van hun innovatie.
European Parliament votes for EMA in the Netherlands
The European Parliament has approved the relocation of the European Medicine Agency (EMA) to Amsterdam, provided that the authorities submit quarterly reports on the progress of the construction of the new office in Amsterdam’s Zuidas business district. A large majority of the parliament (507 against 112) voted for the Netherlands as EMA's new location.
Immune diseases and machine learning feature in new IMI Call for proposals
The Innovative Medicines Initiative (IMI) is launching a new EUR 82 million Call for proposals focusing on immune diseases, imaging, machine learning, and digital clinical trials.
International funding opportunity offered by CARB-X
CARB-X supports early development in the area of antibiotics, other antimicrobial therapeutics, preventatives, diagnostics and devices.The Netherlands: Europe’s most attractive and innovative biopharmaceutical industry environment
With an unrivalled concentration of biopharmaceutical ecosystems, world-class universities and a long history of strategic partnerships between science, industry and government, the Netherlands is a perfect location for biopharmaceutical innovation in Europe.